Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2005
09/14/2005EP1572224A2 Methods and compositions for inhibiting binding of ige to a high affinity receptor
09/14/2005EP1572121A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/14/2005EP1572116A2 Compositions and methods for the treatment of immune related diseases
09/14/2005EP1572102A2 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
09/14/2005EP1572091A2 Compositions and methods for the diagnosis and treatment of tumor
09/14/2005EP1572065A2 Method and pharmaceutical composition for the treatment of multiple sclerosis
09/14/2005EP1571968A2 Compositions and methods for the diagnosis and treatment of tumor
09/14/2005EP1013665B1 Polypeptide having water channel activity and dna sequence
09/14/2005EP0990039B1 Increasing production of proteins in gram-positive microorganisms
09/14/2005EP0833933B1 A vector and method for producing influenza hemagglutinin
09/14/2005EP0705344B1 Adenovirus vectors for gene therapy
09/14/2005CN1668639A Polynucleotides and polypeptides coded by said polynucleotides involved in the synthesis of diketopiperazine derivatives
09/14/2005CN1668636A Recombinant production of mixtures of antibodies
09/14/2005CN1668187A Transgenic ungulates capable of human antibody production
09/14/2005CN1667115A Aspergillus niger strain and its use in solid fermentation production of pectinase
09/14/2005CN1218961C Osteoclast formation inhibitive factor, its nucleotide sequence and preparation method
09/14/2005CN1218749C Recombination protein vaccine for preventing animal aphtha virus infection and uses thereof
09/13/2005US6943241 Full-length cDNA
09/13/2005US6943239 Antigenic fusionprotein carrying Galα1,3Gal epitopes
09/13/2005US6943238 Antibodies to cyclin E2 protein
09/13/2005US6943237 GANP protein
09/13/2005US6943150 Antiapoptosis polypeptides or fusion proteins coded by nucleic acids
09/13/2005US6943020 Death domain containing receptor-4 antibodies
09/13/2005US6943014 Invention provides cDNAs encoding deoxyribonuclease II beta and isolated, purified deoxyribonuclease II beta proteins and antibodies against this protein and antisense agents targeted to cDNA or mRNA encoding deoxyribonuclease II beta
09/13/2005US6943013 DNA expression vector; host cell transformed, transfected or infected with the vector; transgenic cell, tissue or organism; HCDS1 protein
09/13/2005US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
09/13/2005US6942982 FEBP1 protein vector host cells and method for making FEBP1 protein
09/13/2005US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel
09/13/2005US6942965 Hepatitis A virus nucleotide sequences, recombinant proteins and uses thereof
09/13/2005US6942863 Polypeptide for use the prevention of infections associated with tissue grafting
09/13/2005US6942861 Functional bacterial protein, intimin, and its use as an antigen for protecting against infection by or transmission of bacteria expressing intimin-like proteins, such as certain pathogenic strains of Escherichial coli
09/13/2005US6942855 recombinant vaccinia virus having a deletion of the region encoding the C-terminal seven amino acids of the E3L gene product and comprising exogenous DNA; use in genetic vaccines for example
09/13/2005US6942853 Latent fusion protein
09/13/2005CA2335394C Aerothricin analogs, their preparation and use
09/13/2005CA2175476C Opioid receptor: compositions and methods
09/09/2005WO2005083444A1 Protein phosphorylation in t-cell receptor signaling pathways
09/09/2005WO2005083439A1 Protein phosphorylation in anaplastic large cell lymphoma
09/09/2005WO2005083113A1 Protein phosphorylation in c-src signaling pathways
09/09/2005WO2005083104A1 Method of producing liquid cell extract for cell-free protein synthesis
09/09/2005WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof
09/09/2005WO2005083072A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
09/09/2005WO2005082940A1 Anti-nc1 monoclonal antibody
09/09/2005WO2005082933A1 Novel chimeric protein, gene encoding the same, and means of judging leukemia using the gene and the protein
09/09/2005WO2005082930A2 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/09/2005WO2005082927A2 Antihypertensive peptides
09/09/2005WO2005081854A2 Egf receptor epitope peptides and uses thereof
09/09/2005WO2005058957A3 Ztnf 12, a tumor necrosis factor
09/09/2005WO2005051994A3 Ztnf11, a tumor necrosis factor
09/09/2005WO2004108889A3 Hybrid antibodies
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005CA2598394A1 Thrombomodulin derivatives and conjugates
09/09/2005CA2558155A1 Casein derived peptides and therapeutic uses thereof
09/09/2005CA2557500A1 Methods and compositions for the treatment and prevention of hiv infection using trim5.alpha.
09/09/2005CA2557499A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/09/2005CA2556893A1 Antihypertensive peptides
09/09/2005CA2556632A1 Egf receptor epitope peptides and uses thereof
09/09/2005CA2556022A1 Protein phosphorylation in t-cell receptor signaling pathways
09/09/2005CA2556021A1 Protein phosphorylation in anaplastic large cell lymphoma
09/09/2005CA2556019A1 Protein phosphorylation in c-src signaling pathways
09/09/2005CA2555413A1 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/08/2005US20050197497 Used to improve the therapeutic efficacy of current cancer treatment; sensitizing cancerous cells to treatment with conventional anti-tumor drugs
09/08/2005US20050197494 Methods of treating thrombotic diseases with von willebrand factor specific antibodies
09/08/2005US20050197295 Modified annexin proteins and methods for preventing thrombosis
09/08/2005US20050197293 Use of an IL-1 antagonist for treating arthritis
09/08/2005US20050196844 Antibodies to phosphorylated tau, methods of making and methods of use
09/08/2005US20050196838 Reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/08/2005US20050196836 Gamma-glutamylcysteine producing yeast
09/08/2005US20050196833 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods
09/08/2005US20050196832 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/08/2005US20050196831 Human G-protein chemokine receptor (CCR5) HDGNR10
09/08/2005US20050196830 Amino acid modified polypeptides
09/08/2005US20050196829 identifying polymorphisms in gene sequences coding Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide (FCER1A); identifying modulator for prevention and treatment of allergic disorders
09/08/2005US20050196823 Determining concentration of proteins in solution using mass spsectrum analysis of flagged proteins
09/08/2005US20050196815 Method for detecting protein
09/08/2005US20050196754 Nucleotide sequences coding modified immunoglobulin for use in immunodiagnostics and therapy
09/08/2005US20050196753 Human coactivator-associated arginine methyltransferase 1 (hCARM1)
09/08/2005US20050196397 Factor IX/factor IXa activating antibodies and antibody derivatives
09/07/2005EP1571217A1 Increasing production of proteins in gram-positive microorganisms
09/07/2005EP1571216A2 Phosphodiesterase 8A
09/07/2005EP1571212A1 Recombinat protein containing albumin multimer
09/07/2005EP1571160A1 Kit for assaying human low-molecular weight cd14 and antibody
09/07/2005EP1571157A1 LIPIN1 function
09/07/2005EP1570067A2 Methods and compositions for immunization against hiv
09/07/2005EP1569675A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
09/07/2005EP1569674A2 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide
09/07/2005EP1451325A4 Transcription factor stress-related polypeptides and methods of use in plants
09/07/2005EP1151109B1 Fucosyl transferase gene
09/07/2005EP1025237B1 Human checkpoint kinase, hcds1, compositions and methods
09/07/2005EP0851030B1 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO
09/07/2005EP0842282B1 Alfa-beta c4bp-type recombinant heteromultimeric proteins
09/07/2005CN1665934A GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1, 4)-N-acetylglucosaminyltransferase III) expression in plants
09/07/2005CN1665926A Human IgM antibody lysing activated lymphocytes under mediation by homologous complement
09/07/2005CN1665862A Poly-gamma-glutamate having ultra high molecular weight and method for using the same
09/07/2005CN1665836A Phosphoinositolglycan (PIG)-binding protein from adipocytes
09/07/2005CN1665835A DNA sequence and recombinant production of the grass pollen allergen Phl p4
09/07/2005CN1665833A Novel variants of the PapM polypeptide of bacteria of genus streptomyces
09/07/2005CN1665543A Fusions of cytokines and tumor targeting proteins
09/07/2005CN1665534A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1665526A Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
09/07/2005CN1664105A MIP gene clone, recombination, expression and protein purifying method for Legionlla pneumophila